Unveiling the antiviral capabilities of targeting Human Dihydroorotate Dehydrogenase against SARS-CoV-2 (original) (raw)

Pharmaceuticals

Discovery of putative inhibitors against main drivers of SARS-CoV-2 infection: Insight from quantum mechanical evaluation and molecular modeling

Emmanuel Oluwarotimi

Frontiers in Chemistry

View PDFchevron_right

Cytidine Derivatives as SARS-CoV-2 Mpro Inhibitors: Antiviral Prediction, Molecular Docking and Pharmacokinetic Score Investigations

Mohammed Hosen

View PDFchevron_right

SAR-Based Optimization of a 4-Quinoline Carboxylic Acid Analogue with Potent Antiviral Activity

priyabrata das

ACS Medicinal Chemistry Letters, 2013

View PDFchevron_right

Quinoline analogue as a potential inhibitor of SARS-CoV-2 main protease: ADMET prediction, molecular docking and dynamics simulation analysis

Rajeshwara Achur

European Journal of Chemistry

View PDFchevron_right

Computational design for the development of natural molecules as compelling inhibitors against the target SARS-CoV-2: An in-silico attempt

edwin jose

journal of applied pharmaceutical science, 2022

View PDFchevron_right

Virtual screening of quinoline derived library for SARS-COV-2 targeting viral entry and replication

Anju Anju

Journal of Biomolecular Structure and Dynamics, 2021

View PDFchevron_right

Discovery of Promising Inhibitors for SARS-CoV-2 Therapeutic Targets: A Quantum Mechanics and Molecular Modeling study

Emmanuel Oluwarotimi

View PDFchevron_right

In-silico studies on potential inhibitors of SARS-CoV2

International Journal of Biological Innovations

International Journal of Biological Innovations, 2023

View PDFchevron_right

Computational Study of the Therapeutic Potential of Novel Heterocyclic Derivatives against SARS-CoV-2

Oreoluwa Folajimi

COVID, 2021

View PDFchevron_right

Discovery of New Hydroxyethylamine Analogs against 3CL pro Protein Target of SARS-CoV-2: Molecular Docking, Molecular Dynamics Simulation, and Structure−Activity Relationship Studies

Prof. Dhruv Kumar, Brijesh rathi

View PDFchevron_right

In-silico strategies for probing chloroquine based inhibitors against SARS-CoV-2

Satyajit Beura

Journal of Biomolecular Structure and Dynamics, 2020

View PDFchevron_right

Virtual screening-driven drug discovery of SARS-CoV2 enzyme inhibitors targeting viral attachment, replication, post-translational modification and host immunity evasion infection mechanisms

Mark Tristan Quimque

Journal of Biomolecular Structure and Dynamics, 2020

View PDFchevron_right

New findings on ligand series used as SARS-CoV-2 virus inhibitors within the frameworks of molecular docking, molecular quantum similarity and chemical reactivity indices

Jesús Sánchez Márquez

F1000Research

View PDFchevron_right

Molecular docking, binding mode analysis, molecular dynamics, and prediction of ADMET/toxicity properties of selective potential antiviral agents against SARS-CoV-2 main protease: an effort toward drug repurposing to combat COVID-19

yash Singh

Molecular Diversity

View PDFchevron_right

Discovery of Small-Molecule Inhibitors of SARS-CoV-2 Proteins Using a Computational and Experimental Pipeline

Adam Zemla

Frontiers in Molecular Biosciences, 2021

View PDFchevron_right

Structure-based Drug Design, ADME and Molecular Docking analyses of anti-viral agents against SARS-CoV-2 virus, Zika virus and Hepatitis C virus

Peter Solo

Journal of Drug Delivery and Therapeutics

View PDFchevron_right

Combined docking methods and molecular dynamics to identify effective antiviral 2, 5-diaminobenzophenonederivatives against SARS-CoV-2

Shafi Ullah Khan

Journal of King Saud University - Science, 2021

View PDFchevron_right

Structural insight to hydroxychloroquine-3C-like proteinase complexation from SARS-CoV-2: inhibitor modelling study through molecular docking and MD-simulation study

Tapasendra ADHIKARY

Journal of Biomolecular Structure and Dynamics

View PDFchevron_right

Not One, But Five: Virtual Screening-Driven Drug Discovery of SARS-CoV2 Enzyme Inhibitors Targeting Viral Attachment, Replication and Post-Translational Infection Mechanisms

Mark Mendoza

2020

View PDFchevron_right

Unveiling the antiviral capabilities of targeting Human Dihydroorotate Dehydrogenase against SARS-CoV-2 (original) (raw)

Related papers